IL6 and chronic obstructive pulmonary disease: In the study of Moraes et al., there was agreement with this study, the relationship between biomarkers of the inflammatory reaction of COPD patients and the control group, indicated by higher soluble IL-6 levels in the COPD patient group (32.97 ± 31.08 pg/ml) than the control group.